Morgan Stanley Sight Sciences, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 277,843 shares of SGHT stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

277,843

Previous 333,396 16.66%

Holding current value

$1.98 Million

Previous $1.38 Million 30.6%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.27 - $4.25 $181,658 - $236,100	-55,553 Reduced 16.66%	277,843 $955,000
Q2 2025 Aug 15, 2025	SELL	$2.09 - $4.34 $11,008 - $22,858	-5,267 Reduced 1.56%	333,396 $1.38 Million
Q1 2025 May 15, 2025	BUY	$2.36 - $3.58 $140,724 - $213,471	59,629 Added 21.37%	338,663 $812,000
Q4 2024 Feb 14, 2025	BUY	$3.36 - $6.18 $185,391 - $340,987	55,176 Added 24.65%	279,034 $1.02 Million
Q3 2024 May 14, 2025	BUY	$5.49 - $8.31 $331,337 - $501,533	60,353 Added 36.91%	223,858 $1.41 Million

Q3 2024 Nov 14, 2024	BUY	$5.49 - $8.31 $331,337 - $501,533	60,353 Added 36.91%	223,858 $1.41 Million
Q2 2024 May 14, 2025	SELL	$5.13 - $7.15 $592,663 - $826,032	-115,529 Reduced 41.4%	163,505 $1.09 Million
Q2 2024 Oct 17, 2024	BUY	$5.13 - $7.15 $33,109 - $46,146	6,454 Added 4.11%	163,505 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$5.13 - $7.15 $33,109 - $46,146	6,454 Added 4.11%	163,505 $1.09 Million
Q1 2024 Oct 17, 2024	SELL	$4.02 - $5.89 $25,945 - $38,014	-6,454 Reduced 3.95%	157,051 $829,000
Q1 2024 Aug 16, 2024	SELL	$4.02 - $5.89 $160,510 - $235,175	-39,928 Reduced 20.27%	157,051 $829,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.89 $160,510 - $235,175	-39,928 Reduced 20.27%	157,051 $829,000
Q4 2023 Aug 16, 2024	BUY	$1.29 - $5.86 $43,181 - $196,157	33,474 Added 20.47%	196,979 $1.02 Million
Q4 2023 Feb 13, 2024	BUY	$1.29 - $5.86 $47,606 - $216,257	36,904 Added 23.05%	196,979 $1.02 Million
Q3 2023 Nov 15, 2023	SELL	$2.88 - $8.8 $1.38 Million - $4.21 Million	-478,208 Reduced 74.92%	160,075 $539,000
Q2 2023 Aug 14, 2023	SELL	$7.46 - $10.67 $14,711 - $21,041	-1,972 Reduced 0.31%	638,283 $5.28 Million
Q1 2023 May 15, 2023	SELL	$8.44 - $13.35 $514,384 - $813,629	-60,946 Reduced 8.69%	640,255 $5.6 Million
Q4 2022 Feb 14, 2023	BUY	$5.58 - $13.94 $658 - $1,644	118 Added 0.02%	701,201 $8.56 Million
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $2.83 Million - $5.29 Million	463,240 Added 194.77%	701,083 $4.45 Million
Q2 2022 Oct 27, 2022	BUY	$6.61 - $11.99 $987,904 - $1.79 Million	149,456 Added 169.09%	237,843 $2.14 Million
Q2 2022 Aug 15, 2022	BUY	$6.61 - $11.99 $987,904 - $1.79 Million	149,456 Added 169.09%	237,843 $2.14 Million
Q1 2022 Oct 27, 2022	SELL	$11.56 - $17.9 $1.73 Million - $2.68 Million	-149,456 Reduced 62.84%	88,387 $1.02 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $17.9 $270,457 - $418,788	23,396 Added 36.0%	88,387 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$17.36 - $27.36 $1.08 Million - $1.69 Million	61,942 Added 2031.55%	64,991 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $68,114 - $119,215	3,049 New	3,049 $69,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

20.6M

Call Options Held

Put Options Held

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $340M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account